| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 122 | / | 2016 | ||||||||
| Date of issue: | 2016-12-20 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Current report 122 re insiders transactions-Sopharma Trading AD | |||||||||||
| Official market - legal basis | |||||||||||
| art. 19. 3 MAR. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| „Sopharma” AD (the Company) announces that it was notified by „Sopharma Trading” AD related to Ognian Ivanov Donev, that „Sopharma Trading” AD executed the following transactions related to shares in the Company: Date and time of the settlement Operation Number of shares Unit price (BGN) 2016-12-14 Sale 70 2.9850 2016-12-15 Sale 3 000 2.9800 2016-12-16 Sale 1 379 2.9500 2016-12-16 Sale 1 000 2.9500 2016-12-16 Sale 621 2.9500 The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Current report 122 re insiders transactions-Sopharma Trading AD.doc | Current report 122 re insiders transactions-Sopharma Trading AD | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2016-12-20 | Ognian Donev | Executive director | |||
Current report 122 re insiders transactions-Sopharma Trading AD.doc